Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer.

Tomasini, Pascale; Greillier, Laurent; Boyer, Arnaud; Jeanson, Arnaud; Barlesi, Fabrice.

Afiliação

Tomasini P; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations dpt, Marseille, France.
Greillier L; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille Université UM105, Marseille, France.
Boyer A; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations dpt, Marseille, France.
Jeanson A; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille Université UM105, Marseille, France.
Barlesi F; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations dpt, Marseille, France.

J Thorac Dis ; 10(Suppl 9): S1032-S1036, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29850182

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article